ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

RAPT RAPT Therapeutics Inc

7.70
0.00 (0.00%)
Pre Market
Last Updated: 19:56:06
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
RAPT Therapeutics Inc RAPT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 7.70 19:56:06
Open Price Low Price High Price Close Price Previous Close
7.70
more quote information »

Recent News

Date Time Source Heading
10/4/202402:00GLOBERAPT Therapeutics Announces Promising Results from Phase 2..
08/3/202408:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/3/202400:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202400:03EDGAR2Form 8-K - Current report
08/3/202400:00GLOBERAPT Therapeutics Reports Fourth Quarter and Full Year 2023..
06/3/202408:30GLOBERAPT Therapeutics Announces Multiple Late-Breaking..
23/2/202409:13EDGAR2Form 8-K - Current report
21/2/202408:29EDGAR2Form 8-K - Current report
20/2/202423:30GLOBERAPT Therapeutics Announces Clinical Hold on Studies..
15/2/202400:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202400:00GLOBERAPT Therapeutics Bolsters Leadership Team with the..
01/2/202400:00GLOBERAPT Therapeutics to Participate in the Guggenheim..
03/1/202400:00GLOBERAPT Therapeutics to Present at the 42nd Annual J.P. Morgan..
28/11/202300:00GLOBERAPT Therapeutics Announces Publication of Phase 1a/1b..
14/11/202300:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202300:03EDGAR2Form 8-K - Current report
14/11/202300:00GLOBERAPT Therapeutics Reports Third Quarter 2023 Financial..
04/11/202303:03EDGAR2Form 8-K - Current report
04/11/202303:00GLOBERAPT Therapeutics Announces Positive Data, Including..
02/11/202307:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
19/10/202300:00GLOBERAPT Therapeutics Announces Two FLX475 Presentations at the..
31/8/202306:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
18/8/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
12/8/202306:02EDGAR2Form 8-K - Current report
11/8/202322:57EDGAR2Form S-3 - Registration statement under Securities Act of..
11/8/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202322:05EDGAR2Form 8-K - Current report
11/8/202322:00GLOBERAPT Therapeutics Reports Second Quarter 2023 Financial..
07/6/202322:00GLOBERAPT Therapeutics to Participate in the Goldman Sachs Global..
26/5/202307:00GLOBERAPT Therapeutics to Present Biomarker Data Corroborating..
11/5/202322:00GLOBERAPT Therapeutics Reports First Quarter 2023 Financial..
03/5/202322:00GLOBERAPT Therapeutics Announces the Appointment of Michael..

Your Recent History

Delayed Upgrade Clock